Deutsch
Español
Skin Care Pharma has developed the generic version of Advantan.
The 5 formulations of the original product generate a combined turnover of over €80 million.
| Solution: | DCP procedures in 7 countries finish. |
| Milk: | Half time reached in DCP procedure with 6 countries. Approval is expected in 05.2020 |
| Cream: |
DCP procedure started in 7 EU countries. Approval is expected in 12.2020 |
| Ointment: |
The registration trial was completed positively in 01.2020 and preparations for submission are ongoing. Approval is expected in 01-02.2021 |
| Fatty ointment: |
Confirmation of the German authority BfArM concerning the formulation is available |
The finest clothing made is a person’s own skin but, of course, society demands something more than this.
— Mark Twain